High-dose vitamin C infusion for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a special high-dose vitamin C infusion, given based on how your body processes it, for people with advanced solid tumors. It aims to see if this vitamin C therapy can be safely combined with your current or new chemotherapy to help control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- Your cancer must be an advanced or metastatic solid tumor that hasn't responded to standard treatments or has progressed.
- You need to have at least one measurable tumor and an ECOG score of 0 or 1 (able to do light housework or be fully active).
- You should not have calcium oxalate kidney stones, G6PD deficiency, or uncontrolled diabetes (fasting blood sugar over 10).
- Your cancer's catalase test must come back negative, and you can't have brain metastases or active infections like TB, HIV, or hepatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether intravenous vitamin C (ascorbic acid) combined with an immune treatment (adebrelimab) can slow or shrink metastatic colorectal cancer that can’t be removed with surgery. It focuses on tumors that strongly show a specific marker called GLUT3, and aims to see if the combination works better than standard approaches.
This Phase 2 trial tests whether intravenous vitamin C (ascorbic acid) added to chemotherapy can improve outcomes for people with certain relapsed or treatment-resistant lymphomas or chronic myelomonocytic leukemia (CMML). It may help by boosting chemotherapy’s effectiveness and/or changing how the cancer responds.
This trial tests whether high doses of vitamin C, given with standard chemotherapy, can help people with multiple myeloma or related plasma cell disorders who have already tried several treatments. It includes a stem cell transplant step, so you must have stored stem cells.
This trial tests adding high-dose vitamin C (ascorbate) to a standard chemotherapy combination for people with muscle-invasive bladder cancer who cannot take or choose not to take cisplatin. The goal is to find a more affordable and effective treatment option.
This trial tests if adding high-dose vitamin C (ascorbate) to a standard combination of azacitidine and venetoclax can help adults with acute myeloid leukemia (AML) who are not healthy enough for strong chemotherapy. It aims to see if this combination is safe and effective.
This trial is testing if high-dose vitamin C can improve quality of life for people with advanced pancreatic cancer that has continued to grow after two previous treatments. It aims to see if vitamin C can help patients feel better and possibly slow the cancer.
Hear when a new Vitamin C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.